SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories gets nod for emergency use Russia's covid-19 vaccine Sputnik V in India

13 Apr 2021 Evaluate

Dr. Reddy's Laboratories has received approval from expert panel for emergency use of Russia's covid-19 vaccine Sputnik V in the India, with certain conditions. The Drugs Controller General of India (DCGI) will take a final call on the recommendation. If approved, it will be the third covid-19 vaccine to be available in India. The vaccine would be imported from Russia for emergency use in the country.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1355.30 -1.55 (-0.11%)
01-Jul-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1870.70
Dr. Reddys Labs. 1355.30
Cipla 1465.00
Zydus Lifesciences 1114.05
Lupin 2416.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: